Showing results (41-50 of 340) with videos related to

Sort By:
Pageof 34
Clinical Kidney Journal|October 4, 2021
Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKDRosa D Wouda, Femke Waanders, Dick de Zeeuw, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2014
Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-AnalysisHiddo J Lambers Heerspink, Tobias F Kröpelin, Jarno Hoekman, et al.
Diabetes, Obesity & Metabolism|July 8, 2017
Does SGLT2 inhibition with dapagliflozin overcome individual therapy resistance to RAAS inhibition?Sergei Petrykiv, Gozewijn D Laverman, Dick de Zeeuw, et al.
Clinical Chemistry|December 17, 2010
Drug-induced changes in risk/biomarkers and their relationship with renal and cardiovascular long-term outcome in patients with diabetesYan Miao, Paul A Smink, Dick de Zeeuw, et al.
Health and Quality of Life Outcomes|October 1, 2011
A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patientsLiana Hakobyan, Flora M Haaijer-Ruskamp, Dick de Zeeuw, et al.
Medical Care Research and Review : MCRR|May 4, 2011
Review: relation between quality-of-care indicators for diabetes and patient outcomes: a systematic literature reviewGrigory Sidorenkov, Flora M Haaijer-Ruskamp, Dick de Zeeuw, et al.
Kidney International. Supplement|October 16, 2004
Detecting and managing patients with type 2 diabetic kidney disease: proteinuria and cardiovascular diseaseWilliam E Mitch, Shahnaz Shahinfar, Tania Z Dickson, et al.
Medical Care|December 11, 2012
Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohortGrigory Sidorenkov, Jaco Voorham, Flora M Haaijer-Ruskamp, et al.
Plos One|November 9, 2013
Do treatment quality indicators predict cardiovascular outcomes in patients with diabetes?Grigory Sidorenkov, Jaco Voorham, Dick de Zeeuw, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2014
The validity of a patient-reported adverse drug event questionnaire using different recall periodsSieta T de Vries, Flora M Haaijer-Ruskamp, Dick de Zeeuw, et al.
Pageof 34